Synergistic Effect of Chemical Enhancer and Iontophoresis for Transdermal Delivery of Nebivolol Hydrochloride Enhancement of Transdermal drug delivery
Iranian Journal of Pharmaceutical Sciences,
Vol. 12 No. 2 (2016),
1 April 2016
,
Page 9-20
https://doi.org/10.22037/ijps.v12.40773
Abstract
The aim of the present study was to develop and investigate the feasibility of delivering Nebivolol as a transdermal patch by iontophoresis. The passive and electrically assisted transdermal delivery of Nebivolol hydrochloride by iontophoresis will improve the therapeutic efficacy and overcome the difficulties raised in oral drug delivery. Because of its extensive hepatic metabolism and low dose, Nebivolol hydrochloride become a suitable candidate for transdermal administration. The matrix transdermal patches of Nebivolol hydrochloride were prepared and tested for in-vitro drug release and ex-vivo permeation. The study was conducted with the help of silver-silver chloride electrodes by iontophoresis across hairless rat skin. Drug release was evaluated in the presence of iontophoresis field using a current density of 0.5 mA/cm2 or without electric field i.e passive diffusion by the process of electro-migration and electro-osmosis. Drug was measured spectrophotometrically and flux was determined. The flux of Nebivolol significantly increased (P<0.05) with increase in current strength from 0.5 – 1.0 mA/cm2. The findings show that Nebivolol hydrochloride matrix transdermal therapeutic systems could be prepared with the required flux having suitable mechanical properties. It can be concluded from the results that the appliance of iontophoresis with penetration enhancer enhances the flux compared to the passive diffusion.
- Nebivolol hydrochloride
- iontophoresis
- permeation enhancer
- transdermal
- hypertension
- flux
How to Cite
References
[2] Jorge LL, Feres CC, Teles V. Topical preparations for pain relief: efficacy and patient adherence. J Pain Res (2011)4:11–24.
[3] Dixit N, Bali V, Baboota S, Ahuja A, Ali J. Iontophoresisan approach for controlled drug elivery: a review. Curr Drug Deliv (2007)4:1–10.
[4] Ashok Kumar J. Transdermal drug delivery system: an overview. Int J Pharm Sci Rev Res (2010)3:49–54.
[5] Yan G, K Li, WI Higuchi. Evaluation of constant current alternating current iontophoresis for transdermal drug delivery. J Control Release (2005)110:141–150.
[6] Banga AK, Chien YW. Iontophoretic delivery of drugs: fundamentals, developments and biomedical applications. J. Control release (1988)7:1-24.
[7] Tavakoli N, Minaiyan M, Saghaei E. Preparation of diltiazem topical gel for the treatment of anal fissure and invitro, exvivo drug release evaluations. J Kerman Univ Med Sci. (2007)14:167–175
[8] Farmer, ER., Hood., Anoinette, H., 2000. The Pathology of the Skin, 2nd edition.
[9] Heather, AE., Benson. Transdermal drug delivery: Penetration enhancement techniques. (2005)2:23-33.
[10] Packer M, Coats AJ, Fowler MB, Katus HA, DeMets DL Effect of Carvedilol o survival in severe chronic heart failure. N Engl J Med (2001) 344:1651–1658.
[11] Vinay V. Various penetration enhancement techniques in transdermal drug delivery. Int J Pharma Technol (2011)3:2373–2401.
[12] Gupta R, Mukharjee B. Development and in vitro evaluation of diltiazem hydrochloride transdermal patches based on povidone ethyl cellulose matrices. Drug Dev Ind Pharm (2003)29:1–7.
[13] Yousuf M, Ahmad M. Ketotifenfumarate and salbutamol sulphate combined transdermal patch formulations: in vitro release and ex vivo permeation studies. In J Pharm Sci (2013)75:569–577.
[14] Jitendra B. Formulation, optimization and evaluation of matrix type transdermal system of Lisinopril dehydrate using penetration enhancers. Drug Invention Today (2010)2:134–137.
[15] Sebastiani P, Nicoli S, Santi P. Effect of lactic acid and iontophoresis on drug permeation across rabbit ear skin. Int J Pharm. (2005)292:119–126.
[16] Kotwal V, Bhise K, Thube R. Enhancement of iontophoretic transport of diphenhydramine hydrochloride thermosensitive gel by optimization of pH, polymer concentration, electrode design, and pulse rate. AAPS Pharm SciTech. (2007)28:E120.
[17] Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm ActaHelv (1985)60:110–111.
- Abstract Viewed: 266 times
- IJPS_Volume 12_Issue 2_Pages 9-20 Downloaded: 170 times